Home > News > QDC announced the appointment of George Dunbar
April 20th, 2004
QDC announced the appointment of George Dunbar
Abstract:
Dunbar’s experience includes more than 25 years as CEO, director, and senior manager with many private and public bioscience companies. Most recently he worked with investors as CEO to sell Targesome, an early-stage targeted drug delivery start-up. Prior to Targesome, Dunbar was CEO of Epic Therapeutics, a controlled release formulation company sold to Baxter Healthcare in 2002.
Source:
NN
Bookmark:
| Related News Press |
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||